HK2 and ovarian carcinoma: In conclusion, this study involving discussion on the UBA domain of p62 regulating the mitochondrial localisation of HK2 and thus changing the cisplatin sensitivity of ovarian cancer cells can be better understood as the study of the mechanism of subcellular protein localisation for the prognosis of ovarian cancer.